Clinical trial
Glycoprotein Matrix-Bound Iron Improves Absorption Compared to Ferrous Bisglycinate Chelate and Ferrous Fumarate: a Randomized Crossover Trial
NCT06738199 is registered in ClinicalTrials.gov with University of Mary Hardin-Baylor as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycoprotein Matrix-Bound Iron Improves Absorption Compared to Ferrous Bisglycinate Chelate and Ferrous Fumarate: a Randomized Crossover Trial
- Lead sponsor
- University of Mary Hardin-Baylor
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2024
- Completion date
- April 22, 2024
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
evaluation of bioavailability of supplemental forms of iron